Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
A vial punctured 17 months into its 18-month shelf life carries a multi-dose window capped at the manufacturer expiration (roughly 30 days, in that case), not the full 28-day post-puncture window if those overlap
Schultheiss, U
This drug class was originally developed to treat type 2 diabetes
Among late phase trials, Lixisenatide (n = 5) showed the lowest eligibility rates (5.8% Non-Asian US) due to strict HbA1c requirements (7.510%), while Dulaglutide (n = 7) showed the highest variability (SD = 46.2%)
Say Hello to a Happier, Healthier You
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
